Plus Therapeutics (PSTV) Reports New Interim ReSPECT-GBM Phase 2 Trial Data at the Society for NeuroOncology Annual Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Plus Therapeutics Reports New Interim Respect-GBM Phase 2 Trial Data At The Society For Neurooncology Annual Meeting And Will Host Key Opinion Leader ... menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
15.11.2023 - AUSTIN, Texas, Nov. 15, 2023 (GLOBE NEWSWIRE) - Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system . Seite 1